Top 50 Biotech Startup Investors in Canada (July 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Atlantic Canada Opportunities Agency
VC Fund
|
18 | Canada, United States, France | Grant, Debt Financing, Seed | Software, Manufacturing, Health Care | $25k–$2M |
|
Innovacorp
VC Fund
|
18 | Canada, Australia, United States | Seed, Grant, Pre-Seed | Software, Information Technology, Health Care | $18k–$3.1M |
|
Toronto Innovation Acceleration Partners
VC Fund
|
17 | Canada, United States | Pre-Seed, Seed | Health Care, Biotechnology, Software | $22k–$8M |
|
Lumira Ventures
VC Fund
|
17 | United States, Canada | Series A, Series B | Biotechnology, Health Care, Medical | $2.9M–$105M |
|
Anges Quebec
VC Fund
|
17 | Canada, Spain, United States | Seed, Angel | Software, Health Care, Artificial Intelligence | $366k–$3.2M |
|
SOSV
VC Fund
|
16 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
|
FACIT
VC Fund
|
14 | Canada, United States | Seed, Pre-Seed | Biotechnology, Health Care, Medical Device | $1.5M–$8M |
|
Fonds de solidarité FTQ
VC Fund
|
13 | Canada, United States, Israel | Series A, Series B | Manufacturing, Biotechnology, Software | $6.3M–$75M |
|
BDC Venture Capital
VC Fund
|
13 | Canada, United States, Japan | Series A, Seed | Software, Information Technology, Artificial Intelligence | $603k–$17M |
|
Amplitude Venture Capital
VC Fund
|
12 | Canada, United States, Israel | Series B, Series A, Seed | Biotechnology, Health Care, Therapeutics | $2.9M–$142M |
|
BoxOne Ventures
VC Fund
|
12 | Canada, United States, United Kingdom | Seed, Pre-Seed, Series A | Biotechnology, Health Care, Software | $274k–$115M |
|
MaRS Investment Accelerator Fund
VC Fund
|
11 | Canada, United States | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, Health Care | $368k–$14M |
|
Real Ventures
VC Fund
|
10 | Canada, United States, United Kingdom | Seed, Series A, Series B | Software, Artificial Intelligence, Machine Learning | $650k–$50M |
|
Golden Ventures
VC Fund
|
10 | Canada, United States, United Kingdom | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $1.5M–$47M |
|
E-Fund
VC Fund
|
9 | Canada, China, United States | Seed, Pre-Seed | Health Care, Medical, Medical Device | $256k–$4.2M |
|
WUTIF
VC Fund
|
9 | Canada | Seed, Pre-Seed, Series A | Software, Health Care, Biotechnology | $100k–$3.8M |
|
Ontario Centres of Excellence
VC Fund
|
8 | Canada, United States | Seed, Grant, Pre-Seed | Software, Information Technology, Health Care | |
|
Business Development Bank of Canada
VC Fund
|
7 | Canada, United States, Argentina | Seed, Series A | Software, Information Technology, Manufacturing | $275k–$16M |
|
Accelerate Fund
VC Fund
|
7 | Canada, United States | Seed, Series A | Software, Health Care, Medical | $951k–$12M |
|
MEDTEQ+
VC Fund
|
7 | Canada, United States | Seed, Series A | Health Care, Medical Device, Biotechnology | $1.5M–$18M |
|
CTI Life Sciences Fund
VC Fund
|
7 | Canada, United States, Spain | Series A, Series B, Seed | Biotechnology, Therapeutics, Health Care | $3.3M–$62M |
|
Radical Ventures
VC Fund
|
7 | United States, Canada, United Kingdom | Seed, Series A, Series B | Artificial Intelligence, Software, Information Technology | $2M–$200M |
|
VA Angels
VC Fund
|
7 | Canada, United States, India | Seed, Debt Financing | Health Care, Software, Information Technology | $110k–$1.5M |
|
Ontario Centre of Innovation
VC Fund
|
7 | Canada, United States | Seed, Pre-Seed, Grant | Health Care, Medical, Software | $7.3k–$3.2M |
|
GreenSky Ventures
VC Fund
|
7 | Canada, United States, United Kingdom | Seed, Series A | Software, Information Technology, Health Care | $731k–$4.5M |
|
Whitecap Venture Partners
VC Fund
|
6 | Canada, United States, Spain | Series A, Seed, Series B | Health Care, Software, Enterprise Software | $717k–$54M |
|
Garage Capital
VC Fund
|
6 | Canada, United States, South Africa | Seed, Series A, Pre-Seed | Software, Information Technology, Artificial Intelligence | $765k–$50M |
|
iGan Partners
VC Fund
|
6 | Canada, United States, Israel | Seed, Series A | Health Care, Software, Medical | $1.9M–$17M |
|
Genesys Capital
VC Fund
|
6 | Canada, United States | Series A, Series B | Biotechnology, Health Care, Medical | $1.8M–$105M |
|
Ramen Ventures
VC Fund
|
6 | Canada, United States | Seed, Pre-Seed, Angel | Biotechnology, Health Care, Software | $120k–$3.2M |
|
Hedgewood
VC Fund
|
5 | Canada, United States, India | Seed, Series A | Health Care, Software, FinTech | $725k–$17M |
|
Natural Products Canada
VC Fund
|
5 | Canada | Grant, Seed, Series A | Biotechnology, Manufacturing, Food and Beverage | $70k–$4M |
|
1517 Fund
VC Fund
|
5 | United States, Canada, India | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, Information Technology | $240k–$41M |
|
Pallasite Ventures
VC Fund
|
5 | Canada, United States | Seed, Series A, Series B | Software, Health Care, Biotechnology | $988k–$115M |
|
Desjardins Venture Capital
VC Fund
|
5 | Canada, United States | Seed, Series A | Software, Information Technology, Manufacturing | $805k–$22M |
|
Sustainable Development Technology Canada
VC Fund
|
5 | Canada, United States, Brazil | Grant, Seed | Energy, Manufacturing, Software | $73k–$6.5M |
|
Capital Angel Network
VC Fund
|
5 | Canada, United States | Seed, Angel | Software, SaaS, Artificial Intelligence | $10k–$5M |
|
Ontario Brain Institute
VC Fund
|
5 | Canada, United States, France | Grant, Seed | Health Care, Medical Device, Medical | $37k–$14M |
|
Golden Triangle Angel Network
VC Fund
|
5 | Canada, United States | Seed, Angel, Grant | Software, Health Care, Medical | $500k–$2.4M |
|
Versant Ventures
VC Fund
|
5 | United States, Switzerland, Canada | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $4.7M–$108M |
|
National Research Council of Canada Industrial Research Assistance Program
VC Fund
|
5 | Canada, United States, United Kingdom | Grant, Seed | Software, Biotechnology, Health Care | $25k–$2.8M |
|
OrbiMed
VC Fund
|
5 | United States, China, Israel | Series B, Series A, Series C | Biotechnology, Health Care, Medical | $10M–$151M |
|
Natacor Inc.
VC Fund
|
4 | Canada, Australia | Angel, Seed | Biotechnology, Health Care, Medical Device | |
|
Theodorus III
VC Fund
|
4 | Belgium, Canada, France | Seed, Series A | Health Care, Life Science, Biotechnology | $2.2M–$18M |
|
OS Fund
VC Fund
|
4 | United States, Canada | Series A, Seed, Series B | Biotechnology, Health Care, Health Diagnostics | $1.6M–$53M |
|
Viva BioInnovator
VC Fund
|
4 | United States, Canada, China | Seed, Series A, Venture - Series Unknown | Biotechnology, Health Care, Medical | $250k–$20M |
|
Maple Leaf Angels
VC Fund
|
4 | Canada, United States | Seed, Pre-Seed, Angel | Software, Health Care, SaaS | $90k–$2.1M |
|
Concrete Ventures
VC Fund
|
4 | Canada, United Kingdom, Spain | Seed, Pre-Seed | Software, SaaS, Information Technology | $250k–$4.1M |
|
BDC Healthcare Venture
VC Fund
|
4 | Canada | Series B, Series A | Biotechnology, Health Care, Therapeutics | $4.7M–$68M |
|
Groupe Roski
VC Fund
|
4 | Canada, United States | Seed, Series A | Health Care, Biotechnology, Medical | $1.5M–$20M |
| Access all 1152 investors in Canada Biotech startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
The Atlantic Canada Opportunities Agency works to create opportunities for economic growth in Atlantic Canada by helping businesses become more competitive, innovative and productive, by working with diverse communities to develop and diversify local economies, and by championing the strengths of Atlantic Canada. Together, with Atlantic Canadians,we are building a stronger economy.
Show more...Investment focus
- Industry: Software, Manufacturing, Health Care
- Stage:Grant, Debt Financing, Seed
- Geography: Canada, United States, France
Investor stats
- Total investments: 208
- Round size: Seed $25k–$2M; Grant $33k–$2M; Debt Financing $141k–$1.1M
- Lead/follow: 82% lead, 18% follow
Portfolio highlights
- IGNITE — Ignite assists entrepreneurs at all stages, whether they are beginning a firm, growing it, or maintaining long-term success.Ignite has been leading an innovative and knowledge-based strategy to help individuals thrive and businesses prosper.
- PEI BioAlliance — PEI BioAlliance is a not-for-profit organization committed to the advancement of the bioscience industry. The BioAlliance has aided businesses, academic and research institutions, and federal and provincial government agencies in establishing the bioscience sector as a critical pillar in the province's and Atlantic Canada's economicfoundation. It facilitates the use of new technology through research and assists in the identification of new commercial opportunities. The PEI BioAlliance leads the Cluster of business, academic, research, and government organizations committed to increasing the economic impact of the bioscience sector in Prince Edward Island.
- The Halifax Honey — The Halifax Honey is a manufacturing company that provides sweet and spicy condiments made from wildflower honey and real chili peppers.
Innovacorp is an early-stage venture capital firm that helps knowledge-based startups commercialize their technologies in the global marketplace. It invests in early stage Nova Scotia entrepreneurs, combining venture capital with business mentoring and incubation facilities. Innovacorp was established in 1995 and based in Halifax, Canada.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Grant, Pre-Seed
- Geography: Canada, Australia, United States
Investor stats
- Total investments: 155
- Round size: Seed $50k–$3.1M; Grant $25k–$91k; Pre-Seed $18k–$878k
- Lead/follow: 34% lead, 66% follow
- Last fund: May invest from a new fund soon — raised $40M in 2016
Portfolio highlights
- Bright Breaks — Bright offer on-site and virtual amenities for companies and employees. whether your team is on-site, working from home, or in between.
- Planetary — Planetary restores the chemistry of seawater so it can do what it has always done: support life and protect the planet.
- CarbonCure Technologies — CarbonCure Technologies creates, develops, and licenses solutions that consume waste CO2 to make better concrete. It spurs the market shift towards affordable green concrete, by enabling concrete manufacturers to convert waste CO2 into solid minerals, locked away as a solid within concrete during manufacturing. It is a green building technologycompany currently serving concrete product manufacturers in the US and Canada. It offers concrete producers the ability to manufacture green concrete products without compromising on either quality or price.CarbonCure is a retrofit innovation that repurposes CO2 gas from large final emitters as a feedstock in concrete plants. The gas is permanently converted into embedded solid mineral carbonates that yield material, environmental, and production advantages. By enabling concrete manufacturers to consume CO2 into concrete products during manufacturing, the technology differentiates an otherwise traditional commodity concrete product, while achieving superior material performance characteristics. In addition to technology, CarbonCure provides demand-pull marketing and environmental reporting/certification services to reinforce its customers’ exclusive competitive positioning. The technology is licensed at a very low-CAPEX to concrete producers, generating a recurring revenue stream.CarbonCure Technologies was founded in 2007 and is headquartered in Halifax, Nova Scotia.
MaRS Innovation (MI) is a commercialization engine that integrates, centralizes and accelerates time to market of the discovery and intellectual property assets from its 15 world-class research institutions. MI’s discovery and innovation pipeline is derived from $1 billion in annual R&D funding. Created as a not-for-profit organizationthrough the Government of Canada’s Center of Excellence for Commercialization and Research program (CECR), MI has raised $50 million from federal and provincial governments, member institutions and industry partners. MI’s vision is to transform the Toronto-based research enterprise into one of world’s most successful commercialization clusters.Through detailed, market facing due diligence, MI identifies opportunities from Canada’s largest academic cluster for further development and commercialization through project management, intellectual property management, investment and technology development. By crossing the innovation gap, MI transforms these opportunities into successful high-value licensing transactions and financeable start-up companies.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Pre-Seed, Seed
- Geography: Canada, United States
Investor stats
- Total investments: 66
- Round size: Seed $73k–$8M; Pre-Seed $22k–$525k
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- HDAX Therapeutics — HDAX Therapeutics novel modality unlocks a never-seen-before binding mechanism to key biological molecules.
- Radiant Biotherapeutics — Radiant Biotherapeutics: Transformative, multi-valent, multi-specific antibody platform: Multabody
- Grey Matter Neurosciences — Grey Matter Neurosciences is a neurotechnology firm developing new medical devices and drug-device combinations to treat age-related brain illnesses like dementia.
Lumira Ventures, a later stage VC, partners & invests in best-in-class innovative biotherapeutic & medtech entrepreneurs building transformative companies.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B
- Geography: United States, Canada
Investor stats
- Total investments: 117
- Round size: Series A $2.9M–$105M; Series B $12M–$75M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Contraline — Contraline is a medical device company that has developed a proprietary injectable hydrogel platform for use in reproductive and contraceptive applications. Contraline's first product, Adam, is implanted into the vas deferens through a minimally invasive, outpatient procedure and once implanted, the gel effectively blocks sperm. Adam isnon-hormonal, designed to last years, and easily reversible.
- Specific Biologics — Specific Biologics' mission is to develop novel gene editing technologies to treat diseases at the genetic level in cells inside the body.
- Cour Pharmaceuticals Development — Reprogramming the immune system. Restoring lives.At COUR, we develop targeted therapies that incite calm within the immune system and help restore the healt ...
Value-added investors for innovative entrepreneurs.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Angel
- Geography: Canada, Spain, United States
Investor stats
- Total investments: 161
- Round size: Seed $805k–$3.2M; Angel $366k–$1.3M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Zilia — Zilia's non-invasive assessment of biomarkers in the eye redefines the way we prevent, diagnose, and treat various diseases.
- DropGenie — DropGenie is building connected hardware to automate gene editing. They are accelerating the pace of discovery through the generation of standardized and compatible scientific information.
- Gray Oncology Solutions — Gray Oncology Solution is a healthcare enterprise software company that commercializes GrayOS, the operating system for oncology.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
We transform the most promising oncology innovations into highly competitive opportunities that benefit patients, researchers, investors, and Ontario's economy.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical Device
- Stage:Seed, Pre-Seed
- Geography: Canada, United States
Investor stats
- Total investments: 31
- Round size: Seed $1.5M–$8M
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- Esphera SynBio — Creating modified exosomes that can be designed to have targeting moieties on their surface and a variety of protein or RNA payloads in their lumen.
- Hyivy Health — Hyivy Health is working on the first smart pelvic health rehabilitation system for patients and the clinicians who treat them.
- HDAX Therapeutics — HDAX Therapeutics novel modality unlocks a never-seen-before binding mechanism to key biological molecules.
Fonds de solidarité FTQ is a private equity and venture capital firm specializing in investments in start-ups, early venture, mergers, business acquisitions, management buyouts, market development project or a buyout, financing for new programs, organic growth and cash flow, growth and expansion financings, development capital, business succession,financial restructuring, business transition financing, family and non-family buyout, consolidations, turnaround, and leveraged management buyouts. It also invests in new markets, product and business line developments, market diversification, interim financings, new product marketing, additional working capital, purchase of tangible and intangible assets, equipment modernization, equipment purchases or upgrades, and integrator projects. The firm has regional funds that do not invest in retail, real estate, farming, biotechnology, and financial services. Fonds de solidarité FTQ invests in small and medium-sized businesses. It typically invests in export projects, forest products, productivity improvement, natural resources, aerospace, agri-food, wood, pulp and paper, chemicals, construction and construction materials, printing, transportation equipment and automobiles, transportation services, furniture and fixtures, combinatorial chemistry and other lead generating technologies, mining and exploration, social economy, textiles, plastics, life sciences, business services, telecommunications, distribution and consumer goods, environment, equipment and machinery, financial services, information and communication technology, metal products, recreational tourism, and culture sectors. Within the culture sector, Fonds de solidarité FTQ seeks to invest in pre-production and creative projects, production projects, infrastructures and services, post-production projects, distribution, and broadcasting and multiplatform broadcasting. Within the environment sector, it invests in waste management and energy conversion for residual waste; air treatment and reduction of greenhouse gas emissions; processes to reduce industrial energy and water consumption; water treatment; and soil rehabilitation and decontamination (metals and organic compounds). Within the life sciences sector, Fonds de solidarité FTQ focuses on services for the biopharmaceutical industry; nutraceuticals and cosmeceuticals; diagnostics and medical supplies and equipment; biopharmaceuticals and generic drugs; biotechnology, and animal health. Within the tourism sector, it focuses on urban tourism, nature tourism, resort type tourism, and local tourism for Quebecers, and in the textiles sector it invests in companies engaged in development and production of specialty textiles as well as development of industrial applications for the construction, transportation, health and safety, and work apparel industries. Fonds de solidarité FTQ prefers to invest in Quebec and in companies impacting the Québec economy. It focuses on investing in the following regions- Abitibi –Témiscamingue, Bas Saint Laurent, Chaudière-Appalaches, Côte-Nord, Estrie, Gaspésie Îles-de-la-Madeleine, Lanaudière, Laurentides, Laval, Mauricie - Centre-du-Québec, Montérégie, Nord-du-Québec, Outaouais, and Saguenay-Lac-St-Jean. Fonds de solidarité FTQ seeks to invest in projects of $3 million or more and also provides loans of up to $ 2 million. It invests in companies in business succession sector having minimum capitalization of $500,000 and EBITDA of over $35.5 million in case of majority interest; equipment and machinery sector with average investment in excess of $3 million; environment sector with funding needs of more than $500000; financial services sector having net assets between $20 million and $50 million in equity; metal products sector having annual sales of over $5 million and financing needs of at least $2 million; and printing sector having investment needs of over $1 million. In the information technology sector, Fonds de solidarité FTQ seeks to invest $2 million as initial investments while total investments can be more than $10 million. It invests in the form of equity financing (common or preferred shares) and unsecured debt requiring no collateral (debenture). Fonds de solidarité FTQ can take both a minority interest including an equity stake of up to 49 percent as well a majority interest in its portfolio companies in case of business succession financing. It seeks a minority stake for the portfolio companies in the equipment and machinery sector. It typically holds its investments for a period of five to ten years in case of equity financing and for more than ten years in case of business succession financing. Fonds de solidarité FTQ began operation on June 23, 1983. It has its headquarters in Montreal in Canada with additional offices in the same city and Quebec in the same country.
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Software
- Stage:Series A, Series B
- Geography: Canada, United States, Israel
Investor stats
- Total investments: 222
- Round size: Series A $6.3M–$46M; Series B $7.5M–$75M
- Lead/follow: 44% lead, 56% follow
- Last fund: May invest from a new fund soon — last raise in 2016
Portfolio highlights
- Cook it — Cook it is a ready-to-cook meal company in Canada. Cook it's mission is to reduce food waste and to take away the inconvenience associated with weekly meal planning. The company delivers incredibly delicious and easily prepared meals that everyone can proudly cook.
- Carbicrete — CarbiCrete is a carbon removal technology company that enables the production of cement-free, decarbonized concrete.
- Flare — Flare equips your team to shut down cybercrime before it escalates. Detect, prioritize, and remediate external cyber threats with automated Threat Exposure Management.
BDC Venture Capital is a major venture capital investor in Canada, active at every stage of the company's development cycle, from seed through expansion, with a focus on technology-based businesses that have high growth potential and that are positioned to become dominant players in their markets. The company helps create and develop strongCanadian businesses through financing, consulting services and securitization, with a focus on small and medium-sized enterprises.BDC Venture Capital has been involved in venture capital since 1975 and has to date invested in more than 400 companies involved in the areas of Life Sciences, Telecommunications, Information Technology and Advanced Technologies.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Seed
- Geography: Canada, United States, Japan
Investor stats
- Total investments: 409
- Round size: Seed $603k–$5M; Series A $3.3M–$17M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- Sheertex — Sheertex - #1 Bestselling tights in the USA. Ultra-strong sheers engineered for durability and comfort, up to 10x more durable than others.
- Xanadu — Xanadu is a Canadian quantum computing company with the mission to build quantum computers that are useful and available to people everywhere.
- LeddarTech — The leader in environmental sensing, fusion and perception for automotive and mobility, LeddarTech delivers actionable data for autonomous driving and ADAS.
Amplitude Ventures is a full-stack venture capital firm focused on investing in precision medicine at the intersection of biology. and AI
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series A, Seed
- Geography: Canada, United States, Israel
Investor stats
- Total investments: 36
- Round size: Seed $6.6M–$18M; Series A $2.9M–$85M; Series B $35M–$142M
- Lead/follow: 42% lead, 58% follow
- Last fund: May invest from a new fund soon — raised $146M in 2019
Portfolio highlights
- Thryv Therapeutics — LQT Therapeutics is a biopharmaceutical company discovering and developing SGK1 inhibition therapies for Long QT Syndrome and various cardiovascular diseases and cancers.
- Mediar Therapeutics — Mediar Therapeutics is a preclinical stage biotechnology company developing antibody-based therapeutics to halt fibrosis in a variety of organ systems, including lung, liver, kidney, and skin.
- Congruence Therapeutics — ABOUT US We are a drug discovery company that is uniquely harnessing the power of protein dynamics, biophysics, machine learning and computational chemistry. Our Science Traditional drug design is limited At Congruence,
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!BoxOne Ventures is a privately held investment firm that focuses on early-stage companies across the most impactful, interesting and fast-changing sectors.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: Canada, United States, United Kingdom
Investor stats
- Total investments: 65
- Round size: Seed $1.1M–$9.5M; Pre-Seed $274k–$2M; Series A $717k–$115M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Tornado — Digest information from thousands of public filings and your own documents with a versatile AI analyst, plus the reliability of full source attribution.
- Dispersa — Harnessing the power of microbe-derived natural solutions to decarbonize the chemicals industry.
- Opalia — Opalia is introducing a new era of dairy: functional, delicious, and sustainable dairy made from mammary cells.
Working with Ontario talent to develop World Class Companies Learn More
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Pre-Seed, Series A
- Geography: Canada, United States
Investor stats
- Total investments: 162
- Round size: Seed $375k–$4M; Pre-Seed $368k–$1.5M; Series A $2.2M–$14M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- SELL IT9 — Get top cash for your tech with SELLIT9, Canada's trusted trade-in service. Free same-day pickups, convenient drop-off locations, and pre-paid shipping labels nationwide. Fast, secure, and hassle-free!
- TimeSmart.AI — TimeSmart.AI provides a comprehensive solution developed with the guidance of physicians and compliance professionals to help improve organizational efficiencies.TimeSmart.AI delivers a robust, all-in-one solution crafted with input from physicians and compliance experts. It streamlines organizational workflows to boost efficiencies acrosshealthcare operations. Designed for real-world reliability, it helps teams save time while upholding the highest standards of care and regulation.
- Authentic Web — Authentic Web is a Corporate Domain Name Management platform for the New TLD Era.We equip enterprise teams in Digital, Marketing & IT with domain and DNS automation, providing business intelligence to support digital optimization and innovation for digital brands.Our workflow, automation and security protocols address Security andCompliance requirements for Risk, Compliance and IT Security teams to lock down domain assets and support teams to manage DNS network exposures.
Real Ventures is an early-stage venture firm focused on serving daring entrepreneurs with the ambition to create successful, global companies. Since 2007, Real Ventures has dedicated itself to building the Canadian startup ecosystem on the belief that people, not money, build game-changing companies. Real Ventures provides stage-specific guidance,mentorship, and access to networks and resources to fast-track founders’ personal and company growth. Real Ventures manages $325 million across five funds and its active portfolio of 100+ companies is currently valued at $10 billion. www.realventures.com
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Machine Learning
- Stage:Seed, Series A, Series B
- Geography: Canada, United States, United Kingdom
Investor stats
- Total investments: 210
- Round size: Seed $650k–$5M; Series A $2.2M–$22M; Series B $7M–$50M
- Lead/follow: 16% lead, 84% follow
- Last fund: May invest from a new fund soon — raised $132M in 2017
Portfolio highlights
- BenchSci — BenchSci is the world leader in AI-Assisted Reagent Selection and Experiment Design. Our preclinical R&D SaaS platform uses machine learning to help pharmaceutical companies increase their research velocity.
- DropGenie — DropGenie is building connected hardware to automate gene editing. They are accelerating the pace of discovery through the generation of standardized and compatible scientific information.
- Nord Quantique — Nord Quantique creates quantum processors based on second-generation technology.
Golden Ventures is a leading seed-stage venture capital fund, based in Toronto and investing across North America. We back bold teams and their transformative ideas.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: Canada, United States, United Kingdom
Investor stats
- Total investments: 185
- Round size: Seed $1.5M–$7.5M; Series A $6.7M–$32M; Series B $14M–$47M
- Lead/follow: 19% lead, 81% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Cybrid — The Cybrid software development kit & cloud-based platform can enable you to launch crypto trading within weeks, for minimal fees. Save millions in headcount, legal, and operational costs, compared to building your own platform from scratch.
- BenchSci — BenchSci is the world leader in AI-Assisted Reagent Selection and Experiment Design. Our preclinical R&D SaaS platform uses machine learning to help pharmaceutical companies increase their research velocity.
- Forma.ai — Forma.ai's sales performance management software brings comp strategy and execution into one platform, and acts as a single source of truth for sales performance.
The E-Fund (VANTEC Entrepreneurs Fund VCC Inc.) was established in 2011 to invest in promising new ventures in British Columbia in a wide range of industry sectors. They are focused on co-investing with other angel investors and early-stage venture capital firms in seed-stage companies with high growth opportunities.The E-Fund involvesspecific investors in the investment due diligence process depending on their industry experience and knowledge and their particular technical expertise. It is their goal to become the ‘Go-to Braintrust’ for active and in-depth angel investing.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Seed, Pre-Seed
- Geography: Canada, China, United States
Investor stats
- Total investments: 57
- Round size: Seed $474k–$4.2M; Pre-Seed $256k–$1M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Qase — Qase is a B2B SaaS platform that reinvents how law firms and legal organizations manage legal referrals.
- ViewsML — Explore cutting-edge AI solutions for cancer treatment, diagnosis, and research. Discover how clinical labs leverage artificial intelligence for precise cancer detection and diagnosis.
- CereCura Nanotherapeutics — CereCura Nanotherapeutics is developing novel RNA therapeutics for central nervous system disorders.
WUTIF Capital (VCC) Inc. is a novel angel fund that co-invests with angel investors in promising new technology ventures in British Columbia. WUTIF was formed in mid-2003 and made its first investments in late 2004.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Pre-Seed, Series A
- Geography: Canada
Investor stats
- Total investments: 73
- Round size: Seed $100k–$3.8M; Pre-Seed $256k–$1.2M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- ViewsML — Explore cutting-edge AI solutions for cancer treatment, diagnosis, and research. Discover how clinical labs leverage artificial intelligence for precise cancer detection and diagnosis.
- Carbonyx — Carbonyx is a biotechnology company that transforms industrial waste into valuable byproducts while permanently storing carbon dioxide.
- CereCura Nanotherapeutics — CereCura Nanotherapeutics is developing novel RNA therapeutics for central nervous system disorders.
The Ontario Centres of Excellence invests in projects and people to accelerate industry R&D to impact the Ontario economy through the commercialization of leading edge research.OCE invests in- Industry-Academic collaborative research- Commercialization of academic research through licensing and spin off companies- Early stage seedfinancing of start-ups- Skills development for high quality personnelThe Ontario Centres of Excellence is a not-for-profit corporation founded in 1987. Core funding is provided by the Ontario Ministry of Research and Innovation
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Grant, Pre-Seed
- Geography: Canada, United States
Investor stats
- Total investments: 150
- Lead/follow: no public data
Portfolio highlights
- Uride — Welcome to Uride - your reliable and affordable ridesharing service with a community-focus. Enjoy the ease of quick pickups, lower fares, and a user-friendly app designed to make your travels smoother. Start riding today!
- FluidAI Medical — Real-Time Monitoring for Anastomotic Leaks with Origin, by FluidAI. Early data shows FluidAI's Origin can detect leaks an average of 1.6 days earlier.
- Novel Biotechnology — Novel Biotechnology is building high-throughput bacterial platforms for the biotech industry, with a focus on plasmid DNA manufacturing.
We are BDC, the bank for Canadian entrepreneurs. We support small and medium-sized businesses in all industries and at every stage of growth with money and advice. We are the Business Development Bank of Canada.
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Seed, Series A
- Geography: Canada, United States, Argentina
Investor stats
- Total investments: 288
- Round size: Seed $275k–$5M; Series A $3M–$16M
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- Vosker — Vosker provides remote area monitoring tech enabling you to take things further
- TickTrade Systems — smartTrade Technologies is a leading global provider with multi-asset electronic trading platforms, helping buy-side & sell-side institutions
- Renaissance Repair and Supply —
Accelerate Fund supports the growth of early-stage Alberta technology companies with a multi million dollar fund that combines co-investment from angel investors.
Show more...Investment focus
- Industry: Software, Health Care, Medical
- Stage:Seed, Series A
- Geography: Canada, United States
Investor stats
- Total investments: 59
- Round size: Seed $1M–$6.6M; Series A $951k–$12M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — raised $15M in 2020
Portfolio highlights
- Dryrun — From lightening fast data imports and automated forecasts, through to unmatched control to model out scenarios, Dryrun is the choice for CFOs managing cash flow for multi-million dollar businesses. Dryrun integrates with Sage Intacct, QuickBooks Online, Xero and Pipedrive.
- Fairly Staffing — On demand shift filling platform for dental offices and dental professionals.
- Chroma Technologies — Chroma Technologies provides financial technology and property solutions to enhance the rental experiences.
MEDTEQ+ is a non-profit organization for industrial research and innovation in medical technology. The organization accelerates the development of innovative technological solutions to improve patients’ health and quality of life by mobilizing Canadian talents. They bringing together the key players in healthcare and innovation allows them andtheir partners, to offer Canadians access to novel solutions.MEDTEQ’s mission is, through collaborative, industry-led projects, to accelerate innovation and position, on a global scale, products and services developed by the Canadian medical technologies industry.
Show more...Investment focus
- Industry: Health Care, Medical Device, Biotechnology
- Stage:Seed, Series A
- Geography: Canada, United States
Investor stats
- Total investments: 32
- Round size: Seed $1.5M–$4M; Series A $2.9M–$18M
- Lead/follow: 47% lead, 53% follow
- Last fund: May invest from a new fund soon — raised $10M in 2018
Portfolio highlights
- Eli — At-home hormone testing from Eli Health: track cortisol, progesterone, and testosterone with saliva tests that deliver lab-grade results in 20 minutes.
- NURA Medical — Discover NurEx's medication safety software and its novel weight estimation technology, designed for healthcare professionals. Experience easy-to-use pediatric dosing, accurate weight measurement, and streamlined formulary management to enhance patient safety and reduce medication errors. Book a demo today.
- Swiftsure Innovations — Swiftsure Innovations provides registered nurses with the tools required to improve patient outcomes.It develops a medical device that enhances oral care for patients on life support with the aim of decreasing the incidence of ventilator-acquired pneumonia, length of mechanical ventilation, and length of hospital stay.Creative Destruction Labssupports the company.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!CTI Life Sciences Fund is a leading Canadian biotech venture capital firm with a global footprint.
Show more...Investment focus
- Industry: Biotechnology, Therapeutics, Health Care
- Stage:Series A, Series B, Seed
- Geography: Canada, United States, Spain
Investor stats
- Total investments: 27
- Round size: Seed $3.3M–$31M; Series A $7.2M–$62M; Series B $23M–$60M
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- IMV Inc — IMV Inc Inc. applies its novel adjuvanting platform to the development of vaccines for cancer therapy, infectious diseases and animal health. The Company’s DepoVax™ platform is a patented formulation that provides controlled and prolonged exposure of antigens plus adjuvant to the immune system. IMV Inc has advanced two DepoVax-based cancer vaccinesinto Phase I human clinical trials. The Company is also advancing a broad infectious disease pipeline including vaccines in such indications as malaria, respiratory syncytial virus (RSV) and anthrax. In addition to the Company’s human health vaccine strategy, it continues to capture value from animal health vaccine applications. IMV Inc has key partnerships in the animal health sector including an agreement with Pfizer Animal Health.
- Find therapeutics — Finding hope by expanding the frontiers of therapy
- Kainova Therapeutics — Domain Therapeutics is a biopharmaceutical company focused on GPCR in immuno-oncology. Discover more than you think on our innovative cancer treatments tackling GPCR mediated-immunosuppression
Radical Ventures invests in the future of how we live, work and play, partnering with founders who understand the transformational power of AI.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 124
- Round size: Seed $2M–$27M; Series A $7M–$53M; Series B $30M–$200M
- Lead/follow: 48% lead, 52% follow
Portfolio highlights
- BenchSci — BenchSci is the world leader in AI-Assisted Reagent Selection and Experiment Design. Our preclinical R&D SaaS platform uses machine learning to help pharmaceutical companies increase their research velocity.
- Generalist AI — At Generalist, we are on a mission to make general-purpose robots a reality.
- Orbital Industries — Orbital Materials leverages AI to design and deploy advanced materials & climate technologies for the long-term habitability of our planet.
VA Angels, one of Canada’s leading angel investment groups, has member locations in Calgary, Edmonton, Kelowna and Winnipeg. Since 2003 they have done 57 deals worth $28.5 million and are one of the most active angel groups in Canada.
Show more...Investment focus
- Industry: Health Care, Software, Information Technology
- Stage:Seed, Debt Financing
- Geography: Canada, United States, India
Investor stats
- Total investments: 109
- Round size: Seed $110k–$1.5M
- Lead/follow: 3% lead, 97% follow
- Last fund: May invest from a new fund soon — last raise in 2015
Portfolio highlights
- Tonit — Connect with local riders. Discover hundreds of rides & events. Track & share your ride. Share photos & videos with the community.
- PLAYR.gg — Surf Giveaways is the #1 platform to run giveaways, sweepstakes, and contests for gamers. Grow your audience and build your community with giveaways now!
- eThor — Trusted By National Brands Trusted By National Brands Contactless In the age of COVID-19, it's more important than ever to provide your customers a safe way to pay. eThor offers a number of contactless payment options, from Apple Pay, Samsung Pay or other forms of
Ontario Centre of Innovation provides a preeminent research-to-commercialization vehicle in Ontario
Show more...Investment focus
- Industry: Health Care, Medical, Software
- Stage:Seed, Pre-Seed, Grant
- Geography: Canada, United States
Investor stats
- Total investments: 52
- Round size: Seed $366k–$3.2M; Grant $7.3k–$110k; Pre-Seed $146k–$2.3M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Synakis — Synakis patented a biodegradable hydrogel vitreous substitute that is injectable, non-cytotoxic in vitro and in vivo, low-swelling, stable, and optically transparent with a refractive index and density similar to those of the native vitreous.
- Medtech Canada — Medtech Canada provides safe and innovative medical technologies solutions.
- Kare Chemical Technologies — Kare specializes in the research, development, and commercialization of catalysts, precursors, and industrial processes to produce pure cannabinoids (for example, CBD, THC, CBN, and rare cannabinoids) that are chemically identical to plant‑derived versions but made via synthetic routes.
GreenSky Ventures is a Toronto-based firm that makes investments in early-stage Canadian technology companies.GreenSky Ventures seeks early-stage B2B technology companies in Canada, emphasizing protectable IP and experienced management. It makes investments in early-stage technology companies through its affiliated venture capital funds, GreenSkyAccelerator Fund I, II and III. Their principals bring a unique combination of experience in technology, law, and finance to high-growth potential companies and dedicated entrepreneurs.GreenSky Capital was founded in Toronto, Ontario in 2010 by Geoff Simonett and Michael T. R. List.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: Canada, United States, United Kingdom
Investor stats
- Total investments: 65
- Round size: Seed $731k–$3.3M; Series A $1.1M–$4.5M
- Lead/follow: 69% lead, 31% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Derapi — Derapi is a universal API for distributed energy resource (DER) devices, including solar, battery storage, EV chargers, smart thermostats, heat pumps, and other behind-the-meter loads. Derapi unlocks the full value of DERs by removing bottlenecks related to data integration, reducing data infrastructure costs and speeding time to market for DERsoftware developers, DER device manufacturers, and others in the DER ecosystem.
- GridBank — GridBank is a vertical video UGC library for brands that want ready-made social content without managing creators directly. It offers royalty-free, social-native videos you can search in natural language and download for use in organic and paid campaigns.
- Trolley — Trolley is the best payouts platform for businesses needing to pay creators, musicians, artists, freelancers, or on-demand workers.
Whitecap Venture Partners is a Canadian-based Venture Capital fund investing in early stage technology companies. Whitecap is headquartered in Toronto and invests across Canada and the Northeastern US. Since Whitecap’s inception the early 1990s, Whitecap recognises the power of real collaboration between entrepreneurs and investors. This rapportenables them to provide significant value to companies along with strong returns across investment cycles.Whitecap specialises in Information & Communication Technologies (ICT) and Medical Technologies. Whitecap is continually searching for upcoming ventures to support as the next generation of exceptional enterprises.
Show more...Investment focus
- Industry: Health Care, Software, Enterprise Software
- Stage:Series A, Seed, Series B
- Geography: Canada, United States, Spain
Investor stats
- Total investments: 49
- Round size: Seed $717k–$5M; Series A $4.1M–$20M; Series B $8.3M–$54M
- Lead/follow: 55% lead, 45% follow
- Last fund: Likely still investing — raised $102M in 2021
Portfolio highlights
- Frugal —
- Future Fertility — OUR AI-POWERED ASSESSMENTS GUIDE PERSONALIZED FERTILITY TREATMENT DECISIONS IN OVER 180 CLINICS ACROSS 32 COUNTRIES
- Shoebox — Clearwater Clinical designs and manufactures innovative, affordable, medical-grade devices that apply the advantages of mobile technology to common clinical practices.
Built by founders, for founders. Garage Capital helps best-in-class companies jump from garage to growth.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: Canada, United States, South Africa
Investor stats
- Total investments: 132
- Round size: Seed $1.7M–$7.5M; Pre-Seed $765k–$3.6M; Series A $7.3M–$50M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- tofu — tofu is an online marketplace for founders, hiring managers, and talent team leaders to find talent.
- Friendlier — Friendlier aims to reduce single-use plastic waste generated by disposable food packaging. We provide businesses with reusable plastic cups and containers, and take care of delivery, pick-up, and washing.
- Dominion Dynamics — Dominion Dynamics is an advanced technology firm building a dual-use, AI-driven Arctic sensing network designed for both military and civilian applications, focusing on seamless multi-domain coordination and persistent regional surveillance.
iGan Partners is one of Canada's largest healthcare-focused venture capital firms, investing across North America. We provide capital and expertise to scale innovative healthcare solutions.
Show more...Investment focus
- Industry: Health Care, Software, Medical
- Stage:Seed, Series A
- Geography: Canada, United States, Israel
Investor stats
- Total investments: 49
- Round size: Seed $1.9M–$5M; Series A $4M–$17M
- Lead/follow: 45% lead, 55% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Docsi — DOCSI provides preference card optimization, surgeon engagement and supply chain cost reduction through novel digital solutions.
- Exact Imaging — Exact Imaging is the developer of the ExactVu™ system, the first micro-ultrasound operating at 29 MHz that provides unmatched resolution. The system enables visualization and targeting of suspicious regions, in addition to performing systematic TRUS biopsies for prostate cancer imaging.
- Adenocyte — Adenocyte is a privately held medical technology business that focuses on early diagnosis of adenocarcinoma and its precancerous precursor.
Genesys Capital is one of Canada's leading venture capital firms, investing in early-stage healthcare and biotechnology companies to drive innovation and improve lives.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B
- Geography: Canada, United States
Investor stats
- Total investments: 35
- Round size: Series A $1.8M–$21M; Series B $10M–$105M
- Lead/follow: 17% lead, 83% follow
- Last fund: May invest from a new fund soon — raised $125M in 2016
Portfolio highlights
- Flosonics — Flosonics Medical is improving patient care through technology-enabled solutions and services that clinicians, and patients, love.
- Enspire DBS Therapy — Enspire DBS Therapy supports stroke recovery patients using deep brain stimulation with physical rehabilitation to restore motor function. Enspire DBS offers a robust method to mediate the effects of stimulation and stroke rehabilitation.
- Feldan Therapeutics — Feldan Therapeutics has developed a patented peptide-based technology platform, the Feldan Shuttle, which enables fast and safe intracellular delivery. The company's mission is to develop leading-edge therapeutic applications based on its proprietary platform, as demonstrated by its current pipeline of clinical programs taking advantage of theunique characteristics of the Shuttle.
We angel invest in founders who will improve the lives of millions. Based in Toronto, Canada.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Pre-Seed, Angel
- Geography: Canada, United States
Investor stats
- Total investments: 22
- Round size: Seed $1.3M–$3.2M; Pre-Seed $120k–$1.5M
- Lead/follow: 0% lead, 100% follow
- Last fund: May invest from a new fund soon — raised $10M in 2018
Portfolio highlights
- ALT TEX — ALT TEX is creating sustainable textiles regenerated from post-industrial waste.
- Spare — Spare is your all-in-one mobility operations platform, designed to provide an end-to-end platform ecosystem for operating modern paratransit and microtransit systems.
- Mayday — Time is your most valuable asset. Make sure you're spending it wisely.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Hedgewood is an investment firm active in venture capital, internet businesses, real estate, specialty finance, asset management, and private equity.
Show more...Investment focus
- Industry: Health Care, Software, FinTech
- Stage:Seed, Series A
- Geography: Canada, United States, India
Investor stats
- Total investments: 109
- Round size: Seed $725k–$4.3M; Series A $7M–$17M
- Lead/follow: 1% lead, 99% follow
Portfolio highlights
- Unito — Unito is taking on a major problem that people are passionate about solving: they make it easier to collaborate across teams. They don't make users learn new tools and change the way they work. By connecting work management tools, they allow managers, cross-functional teams, departments, and entire companies to benefit from seamlesscollaboration and improved communication. The app syncs projects across a number of tools like Trello, Asana, JIRA, GitHub, Wrike, Zendesk & Hubspot. This is a hard problem of semantics, synchronization, and APIs.
- Vetster — Pet health starts with Vetster. Find and book veterinarians from across North America to provide excellent health care for your pet through video consults. Cats, dogs, reptiles, horses - all pets are welcome.
- Ready, Set, Food! — Ready, Set, Food! makes it easy for parents reduce their baby's risk of developing peanut, egg, and milk allergies by up to 80% with our gentle, daily system.
Maximizing growth in naturally-derived products, technologies and services
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Food and Beverage
- Stage:Grant, Seed, Series A
- Geography: Canada
Investor stats
- Total investments: 20
- Round size: Seed $500k–$3.3M; Grant $70k–$256k; Series A $805k–$4M
- Lead/follow: 55% lead, 45% follow
Portfolio highlights
- Dispersa — Harnessing the power of microbe-derived natural solutions to decarbonize the chemicals industry.
- Scotiaderm — Scotiaderm is a company that manufactures a natural skin barrier formulation that protects against skin damage caused by exposure to urine, feces, sweat, and chaffing.
- BioNorth Solutions — BioNorth Solutions produces some of the most aggressive, consistent and effective microbes available in the hydrocarbon remediation.
1517 Fund is an early stage venture capital fund that supports teams led by dropouts, deep-tech scientists & founders working outside of tracked institutions.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, Canada, India
Investor stats
- Total investments: 131
- Round size: Seed $750k–$7M; Pre-Seed $240k–$3M; Series A $7.6M–$41M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Frenter — Helping equipment rental businesses manage their day-to-day operations so they can focus on growing their business in-person and online. Request a Demo today
- Deepgram — Deepgram helps enterprises unlock the potential of their audio data with custom-trained speech recognition for accuracy and scale. Deepgram's deep learning speech recognition system searches for keywords in transcripts by sound and text within audio and video files, used for transcribing calls, meetings, and voicemails for searchable notes,providing businesses with a fast, high accuracy speech-to-text on an easy-to-use API.The company was founded in 2015 and is headquartered in San Francisco, California.
- Xona — Xona's Pulsar service is the first high-performance alternative to GPS designed to support the age of autonomy. Our constellation of smallsats will provide secure navigation and timing services with the resilience and accuracy needed to enable modern devices to operate safely in any conditions.
Pallasite Ventures is an agile venture capital firm providing early-stage financing for high-growth companies across a variety of industries.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: Canada, United States
Investor stats
- Total investments: 34
- Round size: Seed $988k–$5M; Series A $3.2M–$26M; Series B $14M–$115M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- Ionomr — Ionomr designs & manufactures advanced ion-exchange polymers & membranes that enable high performance and efficiency in applications like water & wastewater treatment, hydrogen production and advanced energy storage.
- Oncoustics AI — Oncoustics is creating and deploying advanced AI solutions for low cost, non-invasive surveillance, diagnostics, and treatment monitoring of diseases with high unmet clinical need. Unlike other players in the space, Oncoustics does not do image recognition. Instead, Oncoustics applies AI to raw ultrasound signals from readily available handheldultrasound devices to rapidly differentiate healthy versus diseased tissues. There's a wealth of information in these raw signals and this approach reveals novel biomarkers that can be aligned with existing standards and categorization systems. Initially targeting liver disease, a $30B global diagnostic market, Oncoustics has filed a Breakthrough Device Designation Request with the FDA for the OnX that detects liver fibrosis and the 510K is underway. Several follow-on liver products are in development. Oncoustics also has clinical data on other organ indications including prostate, kidney, breast and thyroid diseases and cancers.
- Aspect Biosystems — Pioneering the development of bioprinted tissue therapeutics to transform how we treat some of the most elusive diseases.
Desjardins Capital makes it easy to grow your business with financial and strategic support. Investment capital and venture capital can help you meet your business goals.
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Seed, Series A
- Geography: Canada, United States
Investor stats
- Total investments: 135
- Round size: Seed $805k–$5M; Series A $5.7M–$22M
- Lead/follow: 10% lead, 90% follow
- Last fund: May invest from a new fund soon — raised $120M in 2018
Portfolio highlights
- Vention — Design and order custom industrial equipment in days. Fast and easy-to-use cloud CAD, loaded with modular parts, that ship next day.
- Inscora — Inscora provides automated cyber risk assessment and sales enablement tools for cyber insurance brokers.
- Vosker — Vosker provides remote area monitoring tech enabling you to take things further
At Sustainable Development Technology Canada (SDTC), they fund Canadian cleantech projects and coach the companies that lead them as they move their ground-breaking technologies to market.SDTC’s support of cleantech translates into jobs, growth, and export opportunities for Canadian companies, as well as economic, environmental and healthbenefits for all Canadians. They are independent but don’t work alone. A big part of their role is building and sustaining networks of partners and stakeholders from private industry, academia and governments, at home and abroad. They operate at arm’s length and receive funding from the Government of Canada.
Show more...Investment focus
- Industry: Energy, Manufacturing, Software
- Stage:Grant, Seed
- Geography: Canada, United States, Brazil
Investor stats
- Total investments: 185
- Round size: Seed $73k–$1.7M; Grant $878k–$6.5M
- Lead/follow: 77% lead, 23% follow
Portfolio highlights
- Solaires Entreprises Inc — Solaires Entreprises Inc is a Canadian cleantech company located in Victoria, BC, that consists of a team of 23 scientists, engineers, and business professionals. Solaires is focused on developing the next generation of solar cells by replacing silicon with perovskite through an innovative and sustainable manufacturing process resulting inaffordable solar photovoltaics with higher energy conversion efficiency.
- Prairie Robotics — Leading smart camera solutions for sustainable recycling and waste management.
- Progressive Planet Solutions — Progressive Planet Solutions Inc is a metal/mineral based company that deals with the exploration & development of zeolite minerals.
Our goal is to build the region's entrepreneurial community, to make the region the best place to start a business and to facilitate access to investment opportunities for qualified investors.
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Seed, Angel
- Geography: Canada, United States
Investor stats
- Total investments: 98
- Round size: Seed $183k–$5M; Angel $10k–$2M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- Xatoms — At Xatoms, we clean water with Quantum Chemistry and AI, revolutionizing water purification for communities worldwide. Our innovative approach rapidly identifies new, sustainable materials to remove harmful pollutants and pathogens. We aim to alleviate the burden on women and girls in underrepresented communities, transforming the global landscape of water accessibility and empowering a more equitable world. Xatoms is at the forefront of combining scientific innovation with social change.
- RainStick — The RainStick shower is a recirculating shower that saves 80% energy and 80% water but still feels like a luxurious shower.
- Afynia Laboratories — Aima Laboratories is a women's health healthcare company that provides innovative solutions to diagnostic and therapeutic difficulties. AIMA is working on the first non-invasive endometriosis diagnostic tool for the market. If you have chronic pelvic/period pain or are having difficulty becoming pregnant, you may have endometriosis.
The Ontario Brain Institute works to establish Ontario as a world leader in brain research, commercialization and care.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Grant, Seed
- Geography: Canada, United States, France
Investor stats
- Total investments: 53
- Round size: Seed $37k–$14M; Grant $50k–$100k
- Lead/follow: 62% lead, 38% follow
Portfolio highlights
- Cove Neurosciences — Cove Neurosciences are changing the way data is used to study the human brain. Cove Neurosciences is a brain data science's next generation.
- Pearl Interactives — Specializes in co-creating interactive media for children of all abilities for wellness, play, and learning. Our flagship product, a video game system called Bootle BlastTM, uses an innovative mixed reality technology to engage children and youth with neuromotor conditions in exercises that improve functional abilities.
- Raft Digital Therapeutics — Raft Digital Therapeutics constructs a virtual platform for assistance to allow unattended at-home programming. give patients an affordable option that promotes long-term follow-through by making exercise enjoyable. To create goods with enduring appeal, a team assembles industry, technical, and business specialists.
Canada's leading early-stage investor community in Waterloo, funding innovative startups across tech sectors with a strong focus on impact and diversity.
Show more...Investment focus
- Industry: Software, Health Care, Medical
- Stage:Seed, Angel, Grant
- Geography: Canada, United States
Investor stats
- Total investments: 35
- Round size: Seed $500k–$2.4M; Angel $500k–$677k
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Justo — Cashback. Lower listing fees. Experienced local agents. Advanced technology. Free services. Justo is a new real estate brokerage based on a radical idea: Consumers are paying too much to buy or sell a home. That's why we offer a new model, based on fairness and transparency. Looking to buy a home? We'll split our commission with you50/50. Plus, our all-inclusive model covers home inspections and lawyer fees. Selling a home? Save half the listing fee of traditional brokerages, and thousands more with free staging, 3D virtual tours, professional photography and online marketing. Our experienced agents work closely with you to help find the home of your dreams, or sell your home for best the possible price. It just makes sense to use Justo.
- MesoMat — Boost fleet safety, fuel consumption, and operating costs real-time data from your tires.
- Motion Gestures — Motion Gestures is a Canadian machine learning startup specializing in gesture recognition software. Motion Gestures specializes in machine learning-based gesture recognition software and was founded in Waterloo, Canada in 2016. The company aims to enable the rapid development and deployment of gesture-enabled interfaces for systems, devices, andapps. Its software supports advanced 2D and 3D gestures using motion, touch, and vision sensors and can be deployed on the cloud, gateway/hub, and embedded platforms. Developers are offered free licenses to the cloud SDK and can quickly create and test any gesture using their smartphones.
Versant partners with exceptional entrepreneurs to build and fund breakthrough biotechnology companies around the globe.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Switzerland, Canada
Investor stats
- Total investments: 287
- Round size: Series A $4.7M–$84M; Series B $10M–$105M; Series C $12M–$108M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Graphite Bio — Graphite Bio is a next-generation gene editing company focused on therapies that harness targeted gene integration to treat or cure serious diseases
- Lycia Therapeutics — Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras. The company was founded by Carolyn R. Bertozzi in 2019 and is based in San Diego, California, USA.
- Nested Therapeutics — Nested Therapeutics is a Cambridge-based VC-backed stealth biotech company. The company's focus is on finding and creating new precision oncology small-molecule drugs targeted toward cancer genes. Nested Therapeutics was established in 2021 in Cambridge, Massachusetts.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!National Research Council of Canada Industrial Research Assistance Program
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Grant, Seed
- Geography: Canada, United States, United Kingdom
Investor stats
- Total investments: 158
- Round size: Seed $25k–$2M; Grant $37k–$2.8M
- Lead/follow: 55% lead, 45% follow
Portfolio highlights
- Loop Industries — Loop Industries, Inc. is a technology and licensing company whose mission is to accelerate the world’s shift toward sustainable plastic and away from our dependence on fossil fuels. Loop owns patented and proprietary technology that depolymerizes no and low value waste PET plastic and polyester fiber, including plastic bottles and packaging, carpetand polyester textile of any colour, transparency or condition and even ocean plastics that have been degraded by the sun and salt, to its base building blocks (monomers). The monomers are filtered, purified and repolymerized to create virgin-quality Loop™ branded PET plastic resin and polyester fiber suitable for use in food-grade packaging to be sold to consumer goods companies to help them meet their sustainability objectives. Through our customers and production partners, Loop is leading a global movement toward a circular economy by raising awareness of the importance of preventing and recovering waste plastic from the environment to ensure plastic stays in the economy for a more sustainable future for all.
- Drive Hockey Analytics — NHL level player & puck sensor with AI made simple & affordable for amateur hockey. Data driven hockey analytics for evaluations, player development & scouting.
- NORAM Electrolysis Systems Inc — NORAM Electrolysis Systems Inc. designs, builds, and supplies advanced electrolysis and chlor-alkali technology and equipment globally.
Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, China, Israel
Investor stats
- Total investments: 615
- Round size: Series A $10M–$140M; Series B $24M–$151M; Series C $15M–$131M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Avedro — Avedro is a privately held medical device and pharmaceutical company advancing the science and technology of corneal cross-linking. Avedro recently completed its US‐based, multi-centered, Phase III studies of corneal cross-linking for the treatment of progressive keratoconus and corneal ectasia following refractive surgery. Outside the UnitedStates, Avedro has commercialized both VibeX and its KXL System for performing Lasik Xtra and accelerated cross-linking. Additionally, Avedro is developing the science of Thermo‐biomechanics for therapeutic medical applications. The Keraflex® refractive correction procedure is the first technology developed from the Thermo‐biomechanics platform and is a non‐invasive, incision‐less ophthalmic procedure for flattening the cornea without the removal of tissue. Keraflex offers the unique ability to induce refractive change without weakening the cornea’s biomechanical integrity, as happens with Lasik and other refractive correction procedures. Keraflex is commercially available outside of the United States.
- Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with advanced immunological diseases.
- EDDA Technology — EDDA Technology offers computer assistance to the patient care management cycle and enables early detection and diagnosis of diseases.
Natacor Inc. is a firm that provides financial and business advising as well as capital investments.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical Device
- Stage:Angel, Seed
- Geography: Canada, Australia
Investor stats
- Total investments: 10
- Lead/follow: no public data
Portfolio highlights
- Viafoura — Viafoura is the leading audience engagement and community platform trusted by over 800 global media brands. Boost loyalty, grow revenue and activate first-party data.
- Nicoya Lifesciences — Get binding kinetics & affinity data on your benchtop. 600+ innovative researchers worldwide are using OpenSPR to publish faster.
- Vida Fresh Air — Vita Fresh Air Corp has developed and is set to commercialize a new catalytic converter technology, the Multi-Chamber Catalytic Converter (MCCC), which aims to lower emissions, lower fuel consumption, and lower equipment costs. Vida’s mission is to develop automotive products that genuinely improve engine performance and emission control in anethical, economical and sustainable manner.
Theodorus is the spin-off fund of Université Libre de Bruxelles that invests ininvest in early stage projects based on proprietary disruptive technologies.
Show more...Investment focus
- Industry: Health Care, Life Science, Biotechnology
- Stage:Seed, Series A
- Geography: Belgium, Canada, France
Investor stats
- Total investments: 15
- Round size: Seed $3.7M–$18M; Series A $2.2M–$6.6M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- DrugBank — DrugBank augments human intelligence to improve the world’s health. Our suite of products are powered by the world’s most complete and up-to-date pharmaceutical knowledge database. It includes everything there is to know about drugs and how they work in the body. We enable companies to improve healthcare delivery through precision medicine orclinical software applications, as well as uncover insights through data science in drug discovery. Our knowledge base can be integrated into software solutions to help achieve clinical intelligence. Companies can easily scale their usage through our API and launch faster with flexible data modules. By providing users with advanced insights and the right information at the right time, users are empowered to make better health decisions.Our extensive, structured datasets are used to discover novel drug candidates, identify drug repurposing opportunities, and build predictive machine learning models. Companies working with data science can find answers quickly and get drugs to market faster with our evidence-based drug information. Lastly, our publicly available resource, DrugBank Online, is free-to-use with limited datasets available for download for academic and non-commercial researchers. DrugBank has been cited in over 13,000 academic publications and is used by millions of researchers and health professionals globally.
- Simmunome AI — We use AI to create accurate, comprehensive disease models using multi-omic data to determine the probability of success of a drug. Our clinical trial simulations allow you to gain insights, make go/no-go decisions, and de-risk your pipeline, getting you to market faster and reducing your R&D co
- Ability biologics — Ability develops innovative, targeted, immune modulating biotherapeutics to address unmet medical needs in patients with cancer and autoimmune diseases.
We partner with future literate entrepreneurs who understand our unique time and place in history, with the ambition to author a better future for humanity.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Health Diagnostics
- Stage:Series A, Seed, Series B
- Geography: United States, Canada
Investor stats
- Total investments: 48
- Round size: Seed $1.6M–$6M; Series A $5M–$32M; Series B $12M–$53M
- Lead/follow: 15% lead, 85% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Arzeda — Arzeda develops enzyme design technology that presents a new way of thinking about biocatalysis. The company was founded by David Baker and three senior members of his lab to commercialize and further develop its computational enzyme design technology.
- A-Alpha Bio — Measure more protein interactions
- Kenota Health — Kenota Health develops next-generation rapid point-of-care system intended to be used for allergy testing in humans. Kenota's diagnostic tools are safe, simple, and offer a cheaper alternative to allergy testing using a thorough non-invasive technology, enabling physicians to improve patient outcomes.
Viva BioInnovator (VBI) is the specialized investment and incubation arm of Viva Biotech Holdings. We focus on the initial creation and development of biotech startups across all indications and drug types. During the early stages of drug discovery, we can nurture and accelerate a startup's growth from idea to clinical program. VBI'sunique investment and incubation model started out of necessity in 2014. Our roots are in drug discovery services, where we operate world-leading and proprietary drug discovery platforms. While serving big pharma customers from around the globe, we came to realize the huge demand from many entrepreneurs who have great ideas but cannot receive funding to advance their plan due to lack of data. We saw the value in many of these innovative ideas and provided our CRO drug discovery services, operational support, and monetary backing to help these creative scientists embark on the "0 to 1" transformation. This spark launched our "equity for service (EFS)" investment and incubation model. VBI is based in Shanghai, with an office in Boston and personnel in California. As of early 2019, VBI has invested in over 30 companies out of the hundreds of proposals submitted for review and we plan to invest at a rapid pace in the years to come. The majority of our current portfolio companies are US based, but we are open to proposals globally and are excited to see new ideas that fit our investment strategy. If you would like to learn more about us, please visit: www.vivabioinnovator.com Or send an email to innovation@vivabiotech.com If you would like to learn more about our parent company, Viva Biotech, please visit: www.vivabiotech.com
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: United States, Canada, China
Investor stats
- Total investments: 34
- Round size: Seed $2.6M–$20M; Series A $250k–$18M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- HAYA Therapeutics — Pioneering next-generation therapies for fibrotic diseases. Learn more about our approach here.
- Kainova Therapeutics — Domain Therapeutics is a biopharmaceutical company focused on GPCR in immuno-oncology. Discover more than you think on our innovative cancer treatments tackling GPCR mediated-immunosuppression
- Vincere Biosciences — Vincere Biosciences is a JLABS incubator company whose mission is to develop drugs to halt the progression of Parkinson's disease (PD).
Maple Leaf Angels are an experienced group of private investors looking for great entrepreneurs, great products and great companies. Bringing together investment, experience and knowledge, we help accelerate companies to become market leaders in their industry.We focus on four main investment areas as follows:- Information Technology- CleanTechnology- Advanced Manufacturing and Materials- Special Opportunities
Show more...Investment focus
- Industry: Software, Health Care, SaaS
- Stage:Seed, Pre-Seed, Angel
- Geography: Canada, United States
Investor stats
- Total investments: 40
- Round size: Seed $475k–$2.1M; Pre-Seed $90k–$1M
- Lead/follow: 13% lead, 87% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Grüvi — Gruvi is a line of craft brewed alcohol-free beers & wines.
- Wyvern — Discover hyperspectral imaging and Earth observation data from Wyvern. Access research-grade satellite imagery that reveals the hidden reality of our planet.
- EmergConnect — Home page - Localized information, services, and support for Canadian visitors.
Concrete Ventures finds great ideas and founders in Atlantic Canada that are ready to build massively scalable businesses and work with them to grow their businesses.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Pre-Seed
- Geography: Canada, United Kingdom, Spain
Investor stats
- Total investments: 39
- Round size: Seed $600k–$4.1M; Pre-Seed $250k–$878k
- Lead/follow: 23% lead, 77% follow
- Last fund: May invest from a new fund soon — last raise in 2015
Portfolio highlights
- Verna — Verna is a business using geospatial data science to address the climate and nature crises.We help landowners, investors, and policymakers to use land in ways that draw down carbon, enhance biodiversity and generate sustainable returns – e.g. through woodland creation, habitat creation and enhancement, and regenerative agriculture.Verna wasestablished in Borehamwood, Hertford.
- VIVLA — We make exclusive second homes in top European locations accessible to everyone. Buy shares of your home without having to buy the whole property.
- 3D BioFibR — 3D BioFibR is a biomaterial manufacturing company that produces naturally sourced, high-value bio fibers such as spider silk, collagen, chitosan, and others. Preliminary fiber performance data shows the potential applications of these fibers in several global markets, including biomedical engineering, green textiles, defense, and aerospaceengineering. Formed in July 2020, 3D BioFibR was founded on the pioneering research of Dr. John Frampton. 3D BioFibR is focused on novel and proprietary methods of biofiber production that have a quality and scale that is currently not achievable with current methods. 3D BioFibR scientists have demonstrated the ability to make collagen fibers, termed CollaFibR™, that are stronger than natural tendons, and spider silk that is tougher than steel and 2000% more flexible. 3D BioFibR’s vision is to become the global leader in the manmade production of nature’s strongest, lightest and toughest materials at a scale and cost that makes them a competitive solution to the engineering challenges of our day.
BDC Healthcare Venture is a venture capital firm specializes in healthcare investments. The firm prefers to invest in the innovative therapeutics, medical technology, health technology, prevention, diagnostics, personalized treatment, mobile technologies and services, robotics, automation and disease management sectors.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series A
- Geography: Canada
Investor stats
- Total investments: 14
- Round size: Series A $8M–$68M; Series B $4.7M–$30M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- Xagenic — Xagenic Inc., a Toronto, Canada-based molecular diagnostics company developing new technology for decentralized, rapid diagnostic testing, and a true point-of-care platform. Our aim is to enable on-demand, near-patient molecular testing, empowering clinicians in making treatment decisions for their patients at the time of the first consultation.This will dramatically improve patient care and reduce health care costs. Xagenic has adapted this technology to permit rapid, enzyme-free detection of nucleic acids from clinical samples.We are commercializing a simple and fully automated technology platform that will enable widespread decentralized diagnostic testing to be performed outside of clinical laboratories. Our team is developing infectious disease tests that will allow the detection of a variety of analytes in situations where rapid test turnaround will provide clinically actionable results.
- Repare Therapeutics — Repare Therapeutics is a clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to developing novel medicines.
- PHEMI — The PHEMI Trustworthy Health DataLab is a unique, cloud-based, integrated big data management system that allows healthcare organizations to enhance innovation and generate value from healthcare data by simplifying the ingestion and de-identification of data with NSA/military-grade governance, privacy, and security built-in.Conventionalproducts simply lock down data, PHEMI goes further, solving privacy and security challenges and addressing the urgent need to secure, govern, curate, and control access to privacy-sensitive personal healthcare information (PHI). This improves data sharing and collaboration inside and outside of an enterprise—without compromising the privacy of sensitive information or increasing administrative burden.Built on privacy-by-design principles, the software gives researchers, scientists, and clinicians faster access to more information while ensuring that they only see data on a need-to-know basis. Responsible data sharing and a governance framework facilitate compliance with privacy regulations.PHEMI Trustworthy Health DataLab can scale to any size of organization, is easy to deploy and manage, connects to hundreds of data sources, and integrates with popular data science and business analysis tools.For more information, visit https://www.phemi.com/ and follow us on Twitter @PHEMISystems, Linkedin, Youtube, and Facebook
Groupe Roski is a private investment company that has been involved in venture capital since 2013 with companies that improve the quality of life and the environment for individuals.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: Canada, United States
Investor stats
- Total investments: 14
- Round size: Seed $1.5M–$3.9M; Series A $14M–$20M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Spiderwort — Spiderwort is an innovator in all-natural, plant-based biomaterials that have the potential to repair spinal cord injuries and promote healing.
- Groupe Evex — Groupe Evex deals with the commercial real estate projects.
- Marmax — Marmax deals with residential and commercial construction, renovation and roofing.
Biotech Investor funding in Canada at a glance
Stats across 1.4k deals from 1.2k investors.
Access all 1152 investors in Canada Biotech startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotech Investors in Canada investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 1152 investors investing in Canada Biotech startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!